BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29291944)

  • 21. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.
    Day JW; Ricker K; Jacobsen JF; Rasmussen LJ; Dick KA; Kress W; Schneider C; Koch MC; Beilman GJ; Harrison AR; Dalton JC; Ranum LP
    Neurology; 2003 Feb; 60(4):657-64. PubMed ID: 12601109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2.
    Perfetti A; Greco S; Fasanaro P; Bugiardini E; Cardani R; Garcia-Manteiga JM; Riba M; Cittaro D; Stupka E; Meola G; Martelli F
    PLoS One; 2014; 9(4):e93983. PubMed ID: 24722564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myotonic dystrophy type 2.
    Finsterer J
    Eur J Neurol; 2002 Sep; 9(5):441-7. PubMed ID: 12220374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual clinical, laboratory, and muscle histopathological findings in a family with myotonic dystrophy type 2.
    Toth C; Dunham C; Suchowersky O; Parboosingh J; Brownell K
    Muscle Nerve; 2007 Feb; 35(2):259-64. PubMed ID: 17068784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myotonic dystrophy type 2 and related myotonic disorders.
    Meola G; Moxley RT
    J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion.
    Lucchiari S; Pagliarani S; Corti S; Mancinelli E; Servida M; Fruguglietti E; Sansone V; Moggio M; Bresolin N; Comi GP; Meola G
    J Neurol Sci; 2008 Dec; 275(1-2):159-63. PubMed ID: 18804219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.
    Liquori CL; Ikeda Y; Weatherspoon M; Ricker K; Schoser BG; Dalton JC; Day JW; Ranum LP
    Am J Hum Genet; 2003 Oct; 73(4):849-62. PubMed ID: 14505273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
    Meola G; Cardani R
    Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premutation allele pool in myotonic dystrophy type 2.
    Bachinski LL; Czernuszewicz T; Ramagli LS; Suominen T; Shriver MD; Udd B; Siciliano MJ; Krahe R
    Neurology; 2009 Feb; 72(6):490-7. PubMed ID: 19020295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
    Kumar A; Agarwal S; Agarwal D; Phadke SR
    Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization PCR for Detection CTG/CCTG-Repeat Expansions in the Diagnosis of Myotonic Dystrophies.
    Meng YX; Shen HR; Zhao Z; Bing Q; Li N; Hu J
    Ann Clin Lab Sci; 2015; 45(5):502-7. PubMed ID: 26586700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2.
    Bonifazi E; Vallo L; Giardina E; Botta A; Novelli G
    Diagn Mol Pathol; 2004 Sep; 13(3):164-6. PubMed ID: 15322428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myotonic Dystrophies: A Genetic Overview.
    Soltanzadeh P
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2.
    Rossi S; Romano A; Modoni A; Perna F; Rizzo V; Santoro M; Monforte M; Pieroni M; Luigetti M; Pomponi MG; Silvestri G
    Eur Neurol; 2018; 79(3-4):166-170. PubMed ID: 29533949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myotonic dystrophy].
    Nanba E
    Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic variability and molecular genetics in proximal myotonic myopathy.
    Papadimas GK; Kekou K; Papadopoulos C; Kararizou E; Kanavakis E; Manta P
    Muscle Nerve; 2015 May; 51(5):686-91. PubMed ID: 25186227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unusual structures of CCTG repeats and their participation in repeat expansion.
    Guo P; Lam SL
    Biomol Concepts; 2016 Dec; 7(5-6):331-340. PubMed ID: 27879482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.